Molecular Analysis of Oncogenes and Resistance Mechanisms in Lung Cancer | stella

Learn Data Labs For Researchers Find trials matched to me

Learn Data Labs For Researchers Find trials matched to me →

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Privacy ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Molecular Analysis of Oncogenes and Resistance Mechanisms in Lung Cancer | stella

Back to Lung Neoplasms trials

Recruiting

Plain-English translation of NCT01580982 on ClinicalTrials.gov ↗ · Source last updated February 2026 · How we translate trials

Read our Lung Neoplasms research guide →

Trial locations(1 site)

United States

University of Colorado Cancer Center, Aurora, Colorado

Key details

Sponsor

University of Colorado, Denver

Collaborators

National Cancer Institute (NCI), National Institutes of Health (NIH)

Enrollment target

~500 participants

Started

January 2012

Primary completion

January 2028

Age range

18 Years – 85 Years

Last updated on clinicaltrials.gov in February 2026.

Contact the research team directly

Reach out to the team running this trial. Response times vary — some teams are faster than others.

Central contact

Brandi Kubala

University of Colorado, Denver

View full record on ClinicalTrials.gov

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.